Clinical Trial Update: H101 Plus TACE for r/m HNSCC [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 trial evaluating H101 in combination with transarterial chemoembolization (TACE) for recurrent/metastatic head and neck squamous cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• H101 (oncolytic adenovirus H101)

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Oncolytic Virus | Phase 2 | Status: NOT_YET_RECRUITING